COST EFFECTIVENESS OF THE COMBINATION OF BOCEPREVIR PLUS PEGINTERFERON ALPHA AND RIBAVIRIN VERSUS PEGINTERFERON ALFA PLUS RIBAVIRIN IN THE RETREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE I INFECTION

被引：0
|
作者：
Fonseca, M. [1 ]
Tannus, G. [1 ]
Parisi, E.
机构：
[1] Univ Fed Sao Paulo, Axia Bio Consulting, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A139 / A139
页数：1
相关论文
共 50 条
  • [1] COST EFFECTIVENESS OF THE COMBINATION OF BOCEPREVIR PLUS PEGINTERFERON ALPHA AND RIBAVIRIN VERSUS TELAPREVIR PLUS PEGINTERFERON ALFA AND RIBAVIRIN IN THE RETREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE I INFECTION
    Fonseca, M.
    Garran, V
    Araujo, G. T.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A329 - A329
  • [2] COST EFFECTIVENESS OF BOCEPREVIR PLUS PEGINTERFERON ALPHA AND RIBAVIRIN VERSUS TELAPREVIR PLUS PEGINTERFERON ALFA AND RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C (CHC) IN PREVIOUSLY UNTREATED GENOTYPE I PATIENTS
    Fonseca, M.
    Garran, V
    Araujo, G. T.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A328 - A328
  • [3] Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C
    Hauser, Goran
    Awad, Tahany
    Brok, Jesper
    Thorlund, Kristian
    Stimac, Davor
    Mabrouk, Mahasen
    Gluud, Christian
    Gluud, Lise Lotte
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (02):
  • [4] Treatment persistence in and cost of therapy for patients with chronic hepatitis C: Peginterferon alfa-2a plus ribavirin versus peginterferon alfa-2b plus ribavirin
    Brixner, Diana I.
    Ye, Xin
    Chu, Teng-Chiao
    Blumentals, William A.
    Hassanein, Tarek I.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (24) : 2171 - 2178
  • [5] Peginterferon alfa-2b plus ribavirin for retreatment of chronic hepatitis C
    Dalke, DD
    Donovan, J
    Mailliard, M
    Monsour, H
    [J]. GASTROENTEROLOGY, 2004, 126 (04) : A667 - A667
  • [6] Efficacy of daclatasvir plus peginterferon alfa and ribavirin for patients with chronic hepatitis C genotype 4 infection
    Ahmed, Hussien
    Abushouk, Abdelrahman Ibrahim
    Gadelkarim, Mohamed
    Mohamed, Arwa
    Gabr, Mohamed
    Negida, Ahmed
    [J]. BANGLADESH JOURNAL OF PHARMACOLOGY, 2017, 12 (01) : 12 - 22
  • [7] Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia
    Isakov, Vasily
    Nikitin, Igor
    Chulanov, Vladimir
    Ogurtsov, Pavel
    Lukyanova, Ekaterina
    Long, Jianmin
    Wah, Janice
    Helmond, Frans A.
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2016, 8 (06) : 331 - 339
  • [8] Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia
    Vasily Isakov
    Igor Nikitin
    Vladimir Chulanov
    Pavel Ogurtsov
    Ekaterina Lukyanova
    Jianmin Long
    Janice Wahl
    Frans A Helmond
    the P08160 trial Investigators
    [J]. World Journal of Hepatology, 2016, (06) : 331 - 339
  • [9] Peginterferon alfa-2b plus ribavirin for chronic hepatitis C virus infection genotype 4
    Shiha, Gamal
    Elshennaw, Hassan
    Abbas, Baha
    Khaled, Zalata
    Attia, Mohamed
    Farouk, Doaa
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A25 - A25
  • [10] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
    Fried, MW
    Shiffman, ML
    Reddy, KR
    Smith, C
    Marinos, G
    Goncales, FL
    Haussinger, D
    Diago, M
    Carosi, G
    Dhumeaux, D
    Craxi, A
    Lin, A
    Hoffman, J
    Yu, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13): : 975 - 982
12345